Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

80 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Cellular pharmacology of gemcitabine.
Mini E, Nobili S, Caciagli B, Landini I, Mazzei T. Mini E, et al. Among authors: nobili s. Ann Oncol. 2006 May;17 Suppl 5:v7-12. doi: 10.1093/annonc/mdj941. Ann Oncol. 2006. PMID: 16807468 Review.
Immune Checkpoint Inhibitors in Pre-Treated Gastric Cancer Patients: Results from a Literature-Based Meta-Analysis.
Roviello G, Corona SP, D'Angelo A, Rosellini P, Nobili S, Mini E. Roviello G, et al. Among authors: nobili s. Int J Mol Sci. 2020 Jan 10;21(2):448. doi: 10.3390/ijms21020448. Int J Mol Sci. 2020. PMID: 31936762 Free PMC article.
Role of novel hormonal therapies in the management of non-metastatic castration-resistant prostate cancer: a literature-based meta-analysis of randomized trials.
Roviello G, Gatta Michelet MR, D'Angelo A, Nobili S, Mini E. Roviello G, et al. Among authors: nobili s. Clin Transl Oncol. 2020 Jul;22(7):1033-1039. doi: 10.1007/s12094-019-02228-2. Epub 2019 Oct 15. Clin Transl Oncol. 2020. PMID: 31617061 Review.
Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.
Martoni A, Mini E, Pinto C, Nobili S, Gentile AL, Dentico P, Angelelli B, Scicolone S, Piana E, Mazzei T. Martoni A, et al. Among authors: nobili s. Ann Oncol. 2001 Apr;12(4):519-24. doi: 10.1023/a:1011103213297. Ann Oncol. 2001. PMID: 11398887 Clinical Trial.
Pharmacological strategies for overcoming multidrug resistance.
Nobili S, Landini I, Giglioni B, Mini E. Nobili S, et al. Curr Drug Targets. 2006 Jul;7(7):861-79. doi: 10.2174/138945006777709593. Curr Drug Targets. 2006. PMID: 16842217 Review.
Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.
Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S. Tempestini A, et al. Among authors: nobili s. Oncol Res. 2005;16(3):143-56. doi: 10.3727/000000006783981189. Oncol Res. 2005. PMID: 16925115
Analysis of gene expression profiles reveals novel correlations with the clinical course of colorectal cancer.
Cavalieri D, Dolara P, Mini E, Luceri C, Castagnini C, Toti S, Maciag K, De Filippo C, Nobili S, Morganti M, Napoli C, Tonini G, Baccini M, Biggeri A, Tonelli F, Valanzano R, Orlando C, Gelmini S, Cianchi F, Messerini L, Luzzatto L. Cavalieri D, et al. Among authors: nobili s. Oncol Res. 2007;16(11):535-48. doi: 10.3727/096504007783438376. Oncol Res. 2007. PMID: 18306933
Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
Nobili S, Checcacci D, Filippelli F, Del Buono S, Mazzocchi V, Mazzei T, Mini E. Nobili S, et al. J Chemother. 2008 Oct;20(5):622-31. doi: 10.1179/joc.2008.20.5.622. J Chemother. 2008. PMID: 19028627 Clinical Trial.
Natural compounds for cancer treatment and prevention.
Nobili S, Lippi D, Witort E, Donnini M, Bausi L, Mini E, Capaccioli S. Nobili S, et al. Pharmacol Res. 2009 Jun;59(6):365-78. doi: 10.1016/j.phrs.2009.01.017. Epub 2009 Feb 7. Pharmacol Res. 2009. PMID: 19429468 Review.
Gold compounds as anticancer agents: chemistry, cellular pharmacology, and preclinical studies.
Nobili S, Mini E, Landini I, Gabbiani C, Casini A, Messori L. Nobili S, et al. Med Res Rev. 2010 May;30(3):550-80. doi: 10.1002/med.20168. Med Res Rev. 2010. PMID: 19634148 Review.
80 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback